ArticlePeerJ2024

An androgen receptor-based signature to predict prognosis and identification of ORC1 as a therapeutical target for prostate adenocarcinoma.

Linjin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.